Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Cardiac Events in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin

NCT01152606 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01152606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01152606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Cardiac Events in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
August 30, 2007
Completion date
May 31, 2016
Enrollment
3,942 (actual)
Sites
205

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer